Evidence map›Paper›PMID 32681032›Full record

ArticleScientific reports2020

Increased predominance of the matured ventricular subtype in embryonic stem cell-derived cardiomyocytes in vivo.

Hajime Ichimura, Shin Kadota, Toshihide Kashihara, Mitsuhiko Yamada, Kuniaki Ito, Hideki Kobayashi, Yuki Tanaka, Naoko Shiba, Shinichiro Chuma, Shugo Tohyama and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Frontiers in cardiovascular medicine · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Hajime IchimuraDepartment of Regenerative Science and Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
Shin KadotaDepartment of Regenerative Science and Medicine, Shinshu University School of Medicine, Matsumoto, Japan. shinkadota@shinshu-u.ac.jp.
Toshihide KashiharaDepartment of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, Rutgers New Jersey Medical School, Newark, USA.
Mitsuhiko YamadaDepartment of Molecular Pharmacology, Shinshu University School of Medicine, Matsumoto, Japan.
Kuniaki ItoDepartment of Regenerative Science and Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
Hideki KobayashiDepartment of Regenerative Science and Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
Yuki TanakaDepartment of Regenerative Science and Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
Naoko ShibaDepartment of Regenerative Science and Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
Shinichiro ChumaDepartment of Development and Differentiation, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
Shugo TohyamaDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0002-5898-3543
Tatsuichiro SetoDivision of Cardiovascular Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
Kenji OkadaDepartment of Surgery, Division of Cardiovascular Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
Koichiro KuwaharaInstitute for Biomedical Sciences, Shinshu University, Matsumoto, Japan.
Yuji ShibaDepartment of Regenerative Science and Medicine, Shinshu University School of Medicine, Matsumoto, Japan. yshiba@shinshu-u.ac.jp.
Shinshu University · JPKeio University · JPKobe University · JPKyoto University · JPRutgers, The State University of New Jersey · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating evidence suggests that human pluripotent stem cell-derived cardiomyocytes can affect "heart regeneration", replacing injured cardiac scar tissue with concomitant electrical integration. However, electrically coupled graft cardiomyocytes were found to innately induce transient post-transplant ventricular tachycardia in recent large animal model transplantation studies. We hypothesised that these phenomena were derived from alterations in the grafted cardiomyocyte characteristics. In vitro experiments showed that human embryonic stem cell-derived cardiomyocytes (hESC-CMs) contain nodal-like cardiomyocytes that spontaneously contract faster than working-type cardiomyocytes. When transplanted into athymic rat hearts, proliferative capacity was lower for nodal-like than working-type cardiomyocytes with grafted cardiomyocytes eventually comprising only relatively matured ventricular cardiomyocytes. RNA-sequencing of engrafted hESC-CMs confirmed the increased expression of matured ventricular cardiomyocyte-related genes, and simultaneous decreased expression of nodal cardiomyocyte-related genes. Temporal engraftment of electrical excitable nodal-like cardiomyocytes may thus explain the transient incidence of post-transplant ventricular tachycardia, although further large animal model studies will be required to control post-transplant arrhythmia.

Indexed as

Cell DifferentiationRegenerationAction PotentialsBiomarkersEmbryonic Stem CellsFluorescent Antibody TechniqueGene ExpressionGene Expression ProfilingHeart VentriclesImmunohistochemistryMyocytes, CardiacPhylogenyBiomarkers

Identifiers

PMID32681032
PMCPMC7368005
OpenAlexW3042581503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.